Safety of Newer Disease Modifying Therapies in Multiple Sclerosis

In the past decade, the therapeutic arsenal for multiple sclerosis has expanded greatly. Newer more potent disease modifying therapies (DMTs) with varying mechanisms of actions are increasingly used early in the disease course. These newer DMTs include oral therapies (teriflunomide, dimethyl fumarat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalkh, Georges, Abi Nahed, Rachelle, Macaron, Gabrielle, Rensel, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823546/
https://www.ncbi.nlm.nih.gov/pubmed/33375365
http://dx.doi.org/10.3390/vaccines9010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823546/
https://www.ncbi.nlm.nih.gov/pubmed/33375365
http://dx.doi.org/10.3390/vaccines9010012

Ejemplares similares